Sales and Marketing

Showing 15 posts of 11527 posts found.

Global prescriptions cost to hit $1 trillion

November 20, 2013 Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions

The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …

EMA looks to sharpen HTA data output

November 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency

The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …

Healthcare UK appoints medical director

November 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, healthcare uk

Professor Rory Shaw has been hired as the medical director of Healthcare UK to lead the newly-established NHS International Development …

AstraZeneca sells arthritis drug for $35 million

November 20, 2013 Sales and Marketing AstraZeneca, RA, arthritis, horizon, vimovo

AstraZeneca has sold rights to its arthritis treatment Vimovo to speciality pharma firm Horizon Pharma for $35 million.  AZ retains …

Charge more for prescriptions in England, say Reform

November 19, 2013 Sales and Marketing GP, NHS, UK, doctors, prescriptions, reform

Increase prescriptions to £10 and charge the same amount to see a GP if you want to help the NHS …

Merck’s melanoma vaccine impresses

November 19, 2013 Research and Development, Sales and Marketing MK-3475, Merck, Roche, melanoma

Merck has posted impressive results for its new melanoma vaccine MK-3475 as it looks to vie for a place in …

Immunocore promotes non-executive to chairman

November 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles

Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …

Sanofi discards blood cancer drug in late-stage

November 19, 2013 Research and Development, Sales and Marketing Sanofi, Wernicke's encephalopathy, fedratinib

Sanofi has scrapped its regulatory filing plans and late-stage trials for rare bone marrow cancer treatment fedratinib. The reason given …

Scientists map cancer ‘family tree’

November 18, 2013 Research and Development, Sales and Marketing Cancer, DNA, ICR, family tree

A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …

Bayer cancer drug gets EU approval

November 18, 2013 Sales and Marketing Bayer, CHMP, EU, Xtandi, Zytiga, xofigo

Bayer’s prostate cancer treatment Xofigo has been shown the green light by the European Commission.  Xofigo (radium Ra 223 dichloride) …

UK agency urged to ‘press’ EMA on speed reviews

November 18, 2013 Research and Development, Sales and Marketing BIA, EMA, EU, MHRA

A new advisory group for the UK drugs regulator wants Europe to follow the lead of the US by introducing …

NICE tells pharma: don’t blame us for rejections

November 18, 2013 Sales and Marketing Dillon, NHS, NICE, VBP

The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …

Several leadership changes at Bristol-Myers Squibb

November 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made several modifications to its senior management team with appointments and role shuffles being the order of the …

Is the NHS in safe hands?

November 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, McConaghie, NHS

A total of 16 months have passed since Jeremy Hunt took over as health secretary from Andrew Lansley, and in …

Most health apps have ‘limited value’

November 15, 2013 Medical Communications, Sales and Marketing Android, digital, healthcare apps, smartphone apple

In a challenge to pharma marketers everywhere, a new report has declared that the ‘vast majority’ of health-related apps aimed …
The Gateway to Local Adoption Series

Latest content